July 31st 2013
Debu Tripathy, MD, co-leader, Women's Cancer Program, University of Southern California Norris Comprehensive Cancer Center, discusses targeting HER2 in breast cancer.
May 3rd 2013
Debu Tripathy, MD, from the University of Southern California Norris Comprehensive Cancer Center, discusses the targeted therapies that are currently available for the treatment of patients with breast cancer.
April 12th 2013
Debu Tripathy, MD, co-leader, Women's Cancer Program, University of Southern California Norris Comprehensive Cancer Center, discusses maintenance therapy for patients with breast cancer.
February 12th 2013
Debu Tripathy, MD, from the USC Norris Comprehensive Cancer Center, discusses results from the ATLAS trial that compared 5 years of adjuvant tamoxifen to 10 in patients with estrogen receptor-positive early breast cancer.
February 4th 2013
Debu Tripathy, MD, from the University of Southern California Norris Comprehensive Cancer Center, discusses the final analysis of overall survival for the phase III CONFIRM trial.
January 11th 2013
Debu Tripathy, MD, from the USC Norris Comprehensive Cancer Center, discusses a phase II trial that examined the CDK inhibitor PD 0332991 for women with advanced estrogen receptor-positive breast cancer.
November 14th 2012
Debu Tripathy, MD, from the USC Norris Comprehensive Cancer Center, discusses a phase II trial that examined GRN1005 in patients with brain metastases from breast cancer.
October 15th 2012
Debu Tripathy, MD, from the USC Norris Comprehensive Cancer Center, discusses results from the phase III EMILIA trial that examined the T-DM1 for women with HER2-positive breast cancer.
March 16th 2012
Dr. Debu Tripathy, from the USC Norris Comprehensive Cancer Center, Discusses Breast Cancer Prevention
January 12th 2012
Dr. Debu Tripathy, from USC Norris Comprehensive Cancer Center, on the Miami Breast Cancer Conference
December 9th 2011
Dr. Debu Tripathy from USC Norris Comprehensive Cancer Center Discusses the AVEREL Bevacizumab Trial Results
October 11th 2011
Dr. Debu Tripathy from USC Norris Comprehensive Cancer Center Discusses Iniparib Trial Heterogeneity
September 20th 2011
Dr. Debu Tripathy from Norris Comprehensive Cancer Center Discusses Breast Carcinoma Heterogeneity
September 12th 2011
Dr. Debu Tripathy from the USC Norris Comprehensive Cancer Center Discusses Biomarker Use in Clinical Trials
September 1st 2011
Dr. Debu Tripathy from the USC Norris Cancer Center on Connecting Markers to Clinical Outcomes
August 25th 2011
Dr. Debu Tripathy from USC Norris Cancer Center on Determining the Best HER2 Targeted Therapy
August 22nd 2011
Dr. Debu Tripathy from UC Norris Cancer Center Discusses HER2 Targeted Therapies
August 18th 2011
Dr. Debu Tripathy from USC Norris Cancer Center on Completing New Assays After Recurrence
August 16th 2011
Dr. Debu Tripathy from USC Norris Cancer Center Describes the Benefits of the PER Conferences
August 15th 2011
Dr. Debu Tripathy from USC Norris Cancer Center on the Oncotype DX Assay Recurrence Score